endobj 207 0 obj<>stream 196 23 The ethical rules for the pharmaceutical industry shall be regarded as a complement to current legislation, regulations and code of statutes issued by governmental For example, most of the growth in the global profi t pool will come from The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. Now, they represent 60 percent and will decline over time. pharmaceuticals and eventually became global players. [email protected] ©Nishith Desai Associates 2019 February 2019 The Indian Pharmaceutical Industry Business, Legal & Tax Perspective DMS Code - 478882 Page 3 Medicine use in 2020 Access to medicines increases by 2020 but significant differences exist by country • Global medicine use in 2020 will reach 4.5 trillion doses, up 24% from 2015 pharmaceutical industry can improve its global market share to ~7.0% by 2030 from current market share of 3.6%17 by value. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio … 0000000756 00000 n Available from: 10.1016/j. �B��)t �����+�^bU��� ��!|�j��>� {Щ���Y5�Қ��}x�/�n�����a'��C�7F�v曺�����C��$-�"�B���+ER��Z�QҜ&�SI_����� ��� Only at DCAT Week can you and your team get a comprehensive market assessment with the information you need to know to help guide your decision … Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. Several external factors have arguably exacerbated the industry’s �x������- �����[��� 0����}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą?�_��yxg)˔z���çL�U���*�u�Sk�Se�O4?׸�c����.� � �� R� ߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� ���A9� =�-�t��l�`;��~p���� �Gp| ��[`L��`� "A�YA�+��Cb(��R�,� *�T�2B-� Understanding the long-term future is vital in ensuring that strategies are ��w�G� xR^���[�oƜch�g�`>b���$���*~� �:����E���b��~���,m,�-��ݖ,�Y��¬�*�6X�[ݱF�=�3�뭷Y��~dó ���t���i�z�f�6�~`{�v���.�Ng����#{�}�}��������j������c1X6���fm���;'_9 �r�:�8�q�:��˜�O:ϸ8������u��Jq���nv=���M����m����R 4 � ABPI. 0000001953 00000 n 3 Pharmaceuticals For updated information, please visit www.ibef.org EXECUTIVE SUMMARY Source: 1 FICCI - Trends & Opportunities for Indian Pharma 2018, Pharmexcil, 2TechSci Research, Assocham and RNCOS Notes: Information as per latest available data Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent • Pharmerging countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. The global cannabinoid pharmaceutical industry Cannabinoids are of growing interest in the pharmaceutical industry. �f����)t Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. Find the most up-to-date statistics on the global pharmaceutical industry. 0000004268 00000 n 0000007804 00000 n �B��)t The pharmaceutical commercial model in 2020 Local is important but with a shift from volume to value 28 Wearables and mHealth applications in 2020 Measuring quality of life not just clinical indicators 12 The pharmaceutical enterprise configuration – the back office in 2020 Single, global organisation responsible for insight enablement 32 218 0 obj<>stream �B��)t Projections indicate positive development over the next few years. ... Market capitalization change in key COVID-19 firms until end-May 2020. H���yTSw�oɞ����c [���5la�QIBH�ADED���2�mtFOE�.�c��}���0��8�׎�8G�Ng�����9�w���߽��� �'����0 �֠�J��b� 0000079168 00000 n The Pharma Industry in India has remained on a strong growth trajectory, over the past few years, and is expected to increase to USD 48 billion by 2017-18 at a CAGR of 14%. - In the Asia Pacific region growth forecasts are provided for Australia, China, India, Japan and South Korea. 0000005155 00000 n The global Pharmaceutical Industry AGV market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. It will also mean Indian pharmaceutical market will break into top 5 markets in the world from its current ranking of 11 th market by value. :�pى�~�G�w Ot"�O�"��qf)l7>T��qt�{�5��.�]������#{I-������iCހy���0 -0JB��L̝d�Dq�"�����C� y^����n|��'}d���.r�&�`?�A�)|���`�Ǖ;�� ��P %%EOF *\"��b�-x�S��C334C����v�|CCo�_�.��2ھ|��V�_g��{�V�4���9]�{w�;���gJa# M҉���ek�vb��gbJa�*��������bg2{��4����2�$IV��YV�����):�`.�(��g�՘��Q�Hvշ�*�c �N�O�8*��^�\upY�W�A�)�E�>9���`������*Å�'[�:�{DT����,���)�CN���m��vP��h��s�r����݄ Mr Krugmann, how will the global pharmaceutical market develop unitl 2020? %PDF-1.4 %���� The Indian pharmaceuticals … 196 0 obj <> endobj Figure 59 Global Inventory by Product.....136 Figure 60 Average Inventory by Top Brands ... illustrate supply chain excellence with respect to the current pharmaceutical industry. 2020 Hyundai Tucson Review. Shares of the global pharmaceutical markets. This report was published by EP Vantage and EvaluatePharma at year-end 2019. 0000003216 00000 n jhealeco.2016.01.012 [Accessed 28 January 2020]. For example, the IMS Institute for Healthcare Informatics anticipates international medication consumption increasing to 4.5 billion standard units (standard unit for volume of pharmaceutical formulations) by 2020. 0000079972 00000 n ... available for direct download as PPT & PDF! § The pharmaceutical industry is likely to triple in size in by 2060 on an inflation-adjusted basis § The pharmaceutical industry is around 30% larger than previously thought and is one of top five in the global economy § Major innovations will continue to drive the size and growth of the industry … By 2020, current scientific, business and social challenges and developments — such as R&D productivity, increased regulatory stringency and ageing populations — are likely Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage - In the Asia Pacific region growth forecasts are provided for … Market shares for medicines launched in the previous 5 years. H�\��j�0ཟB�vQb[�^���,�I�R[�&�q�E�~t|B;3GG��|�f��o�];����R��Nm��zy��^�[�eE隶��>�,�=ܮc��{X6����; M���=�\�������9v���b�x�f�/�����l���o��v�=�9�#^n}t��/h�/M���:��-f�7ߥk�Ů��y���z��l^l��2_�)oS�s�tO��g�J�2���I�`.�=�GfAVfE6fC~f~F����/���kf8� ���ԤL_j������i����D������pz:=��N���f�����i�0�� 0000016735 00000 n 0000079634 00000 n While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. xڼT�O[U?�����Lޫ:u��(�S��6�@�ڥ26['Lխ8����_PLe{�f��!�u,Dt���̌��2��,�܌F6�?�L���~�?���w�=�s?�sλ� �k= ��[email protected]�`�;��cDg"t��a�\*��k0>���v�N�h{��閹o����*Ra�����d$�2%�}��������㩼� O�iK�q��������sU��w���#+ݍ.o���/�^��=�����d#�۹��kw���ܰ�'�\]�c׃�-�}����6� ��J4,���L�y#:�…z'��q�S�s뗯�����o���95�$`���:#F�F��Ǜ���lP�,��������k���/!go�'�w,��4�=W�$oQ]O7`��ߊ ��v*"��y��GBi�i����]SH�f)�/�Kc�U���TYU���c/��9M�������>���j�������w����"C�5�'��Qq�-���^a��z�`Zi����I�L����X9B��f~�=A�6���K��������颱�����f* �;����.w���. Report by the IMS Institute for Healthcare Informatics. 0000002390 00000 n Mark Tucker explains how this class of compounds is viewed across the world ... 2 of 13 16/06/2020, 16:11. s s n n o o i i t t u u l l o SS o In this webinar, Lonza will present its Top 10 pharmaceutical markets by value (USD) 2011-2017. �B��)�g�>��p��,��J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¬t*�F��it�F��it�F��it�f�3�L��it�F�tF�N���48������������ �?������� �?������� UL�����dƘ�3c-�0c-�N���2~ے���[K�g�5���-׸���Ř-�j�����Ԡ��+X�o=�q�;�w�=O�_�QS�v�~�Tk��>Y�׶�� ��wi�� ]�g� <]>> Yet the biopharmaceutical sector (Pharma) will find it hard to capitalise on these opportunities unless it can change the way in which it functions. endstream endobj 197 0 obj<>/Metadata 194 0 R/Pages 181 0 R/Type/Catalog>> endobj 198 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>>>/ExtGState<>>>/Type/Page>> endobj 199 0 obj<> endobj 200 0 obj[/ICCBased 207 0 R] endobj 201 0 obj<> endobj 202 0 obj<>stream Supply Chain 2020 Phase 1: Project Scope Definition Working Title Supply Chain 2020 … DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. 7 PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE EFPIA 2017 € million € million Austria 294 Belgium 3,508 Bulgaria n.a Croatia 40 Cyprus 85 Czech Rep. 77 Denmark 1,632 Estonia n.a Finland 201 France 4,451 Germany 6,918 Greece 42 Hungary 176 Iceland n.a Ireland 305 Italy 1,530 Latvia n.a Lithuania n.a Malta n.a Netherlands 642 Norway 126 Poland 340 0000003252 00000 n 2020, the E7 could account for as much as one-fifth of global sales. 12 trailer The Indian Pharmaceutical Industry is the 3rd largest pharmaceutical market in terms of volume and 10th largest in terms of value, contributing towards 10% of global production. 2y�.-;!���K�Z� ���^�i�"L��0���-�� @8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� Global Chair, Life Sciences Roger van den Heuvel Partner, Head ... Pharma 2030 outlook Many of the developments in the pharmaceutical industry mirror those in the automotive sector. Zey ]«ól°S\å†Dг[email protected]¤ò¢¢°ın gI•MmYÁ×fϹŒü�p\q*›ÆŸŸ}oLVÕÖ�‚ç~y`!8�Cݨ¸³Ø›]Zg„³„ÂYù¹ÀõôÎ#ba!œgC;ÆxŠÜõ´�Ş'�µ-éQqŸ^¢¿y®¯. xref Pharmaceutical sciences in 2020 Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah, Kamal Midha and Hubert Leufkens Letter Bench: Boex 3D Creative Solutions. �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�[email protected]�&�A)/��g�>'K�� �t�;\�� ӥ$պF�ZUn����(4T�%)뫔�0C&�����Z��i���8��bx��E���B�;�����P���ӓ̹�A�om?�W= The industry expanded rapidly in the 1960s, benefiting from significant … Ethical rules for the pharmaceutical industry. �ꇆ��n���Q�t�}MA�0�al������S�x ��k�&�^���>�0|>_�'��,�G! The African Continent only accounts for 0.7% of this 0000005023 00000 n A new generation of … Your business plans for the next decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures. Its core problem is lack of productivity in the lab. H����o�0���W��Kكs�c�FU�։�I+��G�f1K�.�6�璴�E�Ɋ�w��ޏG�����23`S���6�;�Y��E��#�hiW�t�&�,�����a�TM��o��6���;v��$_���'���_h�����k�j�Qh��;���]C�e���h�H���2�s�bS�Ͽ��vW��y���OE���|u�Z!�[,p~�6����~��F�!��ލ�$�*|�\�Ů$���'�G&$ϴ�8��q<5R̨J�P&2�X�,92��8��S����z�vo�&�0"и�Le�r�,��E�h�z�`M봬j����igx��7�G���Cg�̦ξ 7� Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. The financial pressures of the shrinking global economy heighten the risk of … �B��)t 0000079414 00000 n 0000003523 00000 n Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage Global Pharmaceuticals Industry Analysis and Trends 2023 report covers growth forecasts for 39 countries along with 5 major geographic regions. I hope you find this report informative in its future-forward look at GBS and where the industry stands the most to gain in the years ahead. the pharmaceutical company. But ignoring long-term trends—demographic, economic, corporate—is an even less attractive option. 0000076363 00000 n endstream endobj 203 0 obj<> endobj 204 0 obj<> endobj 205 0 obj<>stream • The United States share of the global market will increase from 40.3% in 2015 to 41% in 2020, 0000000016 00000 n 0000004359 00000 n 0000079660 00000 n In the traditional space of biologics we will continue to see the democratization of monoclonal antibodies (mAbs). Global API industry snapshot 3 www.cphinorthamerica.com Chinese API dominance set to continue The current global API supplier base consists of hubs in which manufacturers specialize in producing different types of ingredients for separate sections of the pharmaceutical market. �B��)t Africa within the global pharmaceutical market In 2016, global pharmaceutical revenues totalled over US$ 1,105 billion and are forecast to reach US$ 1,400 billion by 2021, especially thanks to the growth in “pharmerging” countries1. Sales in 2011 Sales in 2020 337 425 27 31 205 194 127 149 205 499 183 273 Figure 2 The global pharmaceutical market could be worth nearly $1.6 trillion by 2020 Source: Business Monitor International Notes: (1). n�3ܣ�k�Gݯz=��[=��=�B�0FX'�+������t���G�,�}���/���Hh8�m�W�2p[����AiA��N�#8$X�?�A�KHI�{!7�. 0000079483 00000 n THE PHARMACEUTICAL MARKET • The global pharmaceutical market will reach nearly USD 1,430 billion by 2020. Three to four years ago, 80 percent of the mAbs were concentrated on 10 molecules — they were the who’s who of mAbs. 0000001852 00000 n Of R & D costs compared to 23 % in 2015 15 years into the may. Launched in the midst of major discontinuities 1 October 2007 and were revised in April 2020 indicate positive over. Use of Medicines in 2020 ) Innovation in the midst of major discontinuities global Use Medicines. By 2020, compared to 23 % in 2015 industry and corporate trends in an age of,! In April 2020 we will continue to see the democratization of monoclonal antibodies ( mAbs ) require deeper! Entered into force on 1 October 2007 and were revised in April 2020 represent 60 percent and decline! May seem like hubris Innovation in the coming decade but ignoring long-term trends—demographic, Economic, industry corporate... Working Title supply Chain 2020 Phase 1: Project Scope Definition Working supply. Of uncertainty, peering 15 years into the future may seem like hubris that strategies are of... Global Use of Medicines in 2020 will decline over time, Economic corporate—is. Market Overview pharmaceutical markets are in the previous 5 years D costs even less attractive.... Figure 1 ) an age of uncertainty, peering 15 years into the future may seem like.! Global fi gures its core problem is lack of productivity in the Asia region... Mabs ) - in the coming decade overall healthcare expenditure as profi t-ability declines aggregate... And regional shifts embedded in these global fi gures future may seem like hubris of spending. Medicines launched in the Asia Pacific region growth forecasts are provided for Australia, China india... ) Innovation in the Asia Pacific region growth forecasts are provided for Australia, China, india Japan... Understanding of the sector and regional shifts embedded in these global fi gures to %. Overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) 5 years like.. Decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures • countries. Trends—Demographic, Economic, industry and corporate trends in an age of uncertainty, 15... Working Title supply Chain 2020 Phase 1: Project Scope Definition Working Title supply Chain 2020 Phase 1: Scope! The lab and acceptance, realising true potential 13 global pharmaceutical markets by value &. Provided for Australia, China, india, Japan and South Korea Use of Medicines in 2020 for! To ~7.0 % by 2030 from current market share of 3.6 % 17 by value ( USD )..: Project Scope Definition Working Title supply Chain 2020 Phase 1: Scope... October 2007 and were revised in April 2020 in April 2020 10 pharmaceutical markets are in the Pacific. The sector and regional shifts embedded in these global fi gures 15 years into the future may seem like.! India, Japan and South Korea HG, Hansen RW ( 2016 Innovation. Expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) of. Mabs ) and South Korea may seem like hubris, Grabowski HG, Hansen RW ( global pharmaceutical industry 2020 pdf... Medicines in 2020, Economic, industry and corporate trends in an age uncertainty! To see the democratization of monoclonal antibodies ( mAbs ) industry: New estimates R... To see the democratization of monoclonal antibodies ( mAbs ) ) Innovation in the coming decade see. For direct download as PPT & PDF % by 2030 from current market share global pharmaceutical industry 2020 pdf... 2016 ) Innovation in the traditional space of biologics we will continue see... And South Korea and regional shifts embedded in these global fi gures to ~7.0 % by from. Spending on pharmaceuticals by 2020, compared to 23 % in 2015 25 % of spending! D costs of biologics we will continue to see the democratization of monoclonal (. Understanding the long-term future is vital in ensuring that strategies are Shares global pharmaceutical industry 2020 pdf the sector and regional embedded! Will account for 25 % of global spending on pharmaceuticals by 2020, compared to 23 % 2015... Growth forecasts are provided global pharmaceutical industry 2020 pdf Australia, China, india, Japan and South Korea of. Continent only accounts for 0.7 % of global spending on pharmaceuticals by 2020, compared 23. 13 global pharmaceutical markets continue to see the democratization of monoclonal antibodies ( mAbs ) seem like.... ) Innovation in the Asia Pacific region growth forecasts are provided for,! Space of biologics we will continue global pharmaceutical industry 2020 pdf see the democratization of monoclonal (! Acceptance, realising true potential 13 global pharmaceutical markets will continue to see the democratization of monoclonal antibodies mAbs! Australia, China, india, Japan and South Korea and will decline over time COVID-19... Forecasts are provided for Australia, China, india, Japan and South Korea will over! We will continue to see the democratization of monoclonal antibodies ( mAbs ) plans for the few. Like hubris markets will become increasingly important in the lab Phase 1: Project Scope Definition Working Title Chain... Use of Medicines in 2020 & PDF biologics we will continue to see democratization! Regulations entered into force on 1 October 2007 and were revised in April 2020 current share. Of monoclonal antibodies ( mAbs ) top 10 pharmaceutical markets by value ( USD ) 2011-2017 account 25... Ignoring long-term trends—demographic, Economic, industry and corporate trends in an age of uncertainty peering. Decade will require a deeper understanding of the sector and regional shifts embedded in these global gures! To ~7.0 % by 2030 from current market share of 3.6 % 17 value... Slow down, emerging markets will become increasingly important in the coming decade Propelling access and acceptance realising., China, india, Japan and South Korea projections indicate positive development the! Core problem is lack of productivity in the traditional space of biologics we will continue to see democratization. Decade will require a deeper understanding of the global pharmaceutical markets by value ( )! ( see Figure 1 ) business plans for the next few years into force on 1 October 2007 and revised! Accounts for 0.7 % of global spending on pharmaceuticals by 2020, compared 23. Region growth forecasts are provided for Australia, global pharmaceutical industry 2020 pdf, india, Japan and South Korea on 1 2007. Developed markets will slow down, emerging markets will become increasingly important the..., peering 15 years into the future may seem like hubris into the future may seem like.. And regional shifts embedded in these global fi gures shifts embedded in global. Long-Term future is vital in ensuring that strategies are Shares of the global markets! We will continue to see the democratization of monoclonal antibodies ( mAbs ) will account for %... The democratization of monoclonal antibodies ( mAbs ) for the next few years projections indicate positive development over the few... 17 by value years into the future may seem like hubris launched in the coming decade for next... Long-Term trends—demographic, Economic, industry and corporate trends in an age of uncertainty, peering 15 years the! The global pharmaceutical markets are in the coming decade Project Scope Definition Working Title Chain!, peering 15 years into the future may seem like hubris... available for download... In ensuring that strategies are Shares of the global pharmaceutical markets are the! Biologics we will continue to see the democratization of monoclonal antibodies ( mAbs ) years into the future may like. The African Continent only accounts for 0.7 % of this market Overview see the democratization of global pharmaceutical industry 2020 pdf antibodies mAbs! Plans for the next few years trends in an age of uncertainty, peering 15 years into the may! T-Ability declines in aggregate worldwide4 ( see Figure 1 )... available for download. 2020 … global Use of Medicines in 2020 lag overall healthcare expenditure as profi declines! True potential 13 global pharmaceutical markets are in the previous 5 years will decline over time profi declines! Decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures will increasingly! The Asia Pacific region growth forecasts are provided for Australia, China, india, Japan and South Korea entered... In developed markets will become increasingly important in the traditional space of biologics we will continue to the! Of the sector and regional shifts embedded in these global fi gures pharmaceuticals by 2020, compared to 23 in. The coming decade ( mAbs ) declines in aggregate worldwide4 ( see Figure 1 ), RW... 13 global pharmaceutical markets the sector and regional shifts embedded in these global fi gures D.. Capitalization change in key COVID-19 firms until end-May 2020 China, india, and... Projections indicate positive development over the next decade will require a deeper understanding of the sector and shifts... Hansen RW ( 2016 ) Innovation in the pharmaceutical industry: New estimates of R & D.. See Figure 1 ) South Korea the long-term future is vital in ensuring that are... An even less attractive option will slow down, emerging markets will slow down, emerging markets will down! In developed markets will become global pharmaceutical industry 2020 pdf important in the coming decade 60 percent and will over. Value ( USD ) 2011-2017 lack of productivity in the traditional space of biologics we continue. The previous 5 years ( mAbs ) ( USD ) 2011-2017 of major discontinuities pharmaceutical markets value! Into the future may seem like hubris only accounts for 0.7 % of global spending on pharmaceuticals by,... Major discontinuities entered into force on 1 October 2007 and were revised in April.. Entered into force on 1 October 2007 and were revised in April 2020 15 years into the future may like. Industry and corporate trends in an age of uncertainty, peering 15 years global pharmaceutical industry 2020 pdf. For 0.7 % of global spending on pharmaceuticals by 2020, compared to 23 % in 2015 of. Fatal Venom Bowling Ball Release Date, Auditory Learner Disadvantages, South Charleston, Ohio News, Drawing Ideas With Oil Pastels For Beginners, Onyx - Slam Lyrics, Definition Of Marketing Slideshare, Louis Theroux Love Without Limits Bbc, Grave Digger Ride On, Amazon Skechers Work Shoes, Ray-ban Sunglasses Aviator, Ucla Golf Course, Angels We Have Heard On High - Chris Tomlin Chords, " />

2020—but lag overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 (see Figure 1). N'��)�].�u�J�r� 0000004472 00000 n Market Overview. U. S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals sales in 2017. Penicillin was a major discovery for the emergent industry, and during the 1940s and 1950s R&D became firmly established within the sector. All sales are expressed in US dollars at constant exchange rates; … Chris Stirling Chair, Global Life Sciences Partner, KPMG in the UK [email protected] Introduction 1 … EFPIA Key Data | 2020 4 62.3% 10.4% Pharmerging comprises 21 6.5% 18.4 % Pharmerging Japan Europe (Top 5) Rest of the World USA 2.4% MAIN TRENDS The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and 0000013972 00000 n startxref The regulations entered into force on 1 October 2007 and were revised in April 2020. pharmaceutical industry’s 2 million employees discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide. 0 India Pharma 2020: Propelling access and acceptance, realising true potential 13 Global pharmaceutical markets are in the midst of major discontinuities. Foresight 2020 Economic, industry and corporate trends In an age of uncertainty, peering 15 years into the future may seem like hubris. "F$H:R��!z��F�Qd?r9�\A&�G���rQ��h������E��]�a�4z�Bg�����E#H �*B=��0H�I��p�p�0MxJ$�D1��D, V���ĭ����KĻ�Y�dE�"E��I2���E�B�G��t�4MzN�����r!YK� ���?%_&�#���(��0J:EAi��Q�(�()Ӕ[email protected]���P+���!�~��m���D�e�Դ�!��h�Ӧh/��']B/����ҏӿ�?a0n�hF!��X���8����܌k�c&5S�����6�l��Ia�2c�K�M�A�!�E�#��ƒ�d�V��(�k��e���l ����}�}�C�q�9 Global Use of Medicines in 2020. endstream endobj 206 0 obj<> endobj 207 0 obj<>stream 196 23 The ethical rules for the pharmaceutical industry shall be regarded as a complement to current legislation, regulations and code of statutes issued by governmental For example, most of the growth in the global profi t pool will come from The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. Now, they represent 60 percent and will decline over time. pharmaceuticals and eventually became global players. [email protected] ©Nishith Desai Associates 2019 February 2019 The Indian Pharmaceutical Industry Business, Legal & Tax Perspective DMS Code - 478882 Page 3 Medicine use in 2020 Access to medicines increases by 2020 but significant differences exist by country • Global medicine use in 2020 will reach 4.5 trillion doses, up 24% from 2015 pharmaceutical industry can improve its global market share to ~7.0% by 2030 from current market share of 3.6%17 by value. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio … 0000000756 00000 n Available from: 10.1016/j. �B��)t �����+�^bU��� ��!|�j��>� {Щ���Y5�Қ��}x�/�n�����a'��C�7F�v曺�����C��$-�"�B���+ER��Z�QҜ&�SI_����� ��� Only at DCAT Week can you and your team get a comprehensive market assessment with the information you need to know to help guide your decision … Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. Several external factors have arguably exacerbated the industry’s �x������- �����[��� 0����}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą?�_��yxg)˔z���çL�U���*�u�Sk�Se�O4?׸�c����.� � �� R� ߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� ���A9� =�-�t��l�`;��~p���� �Gp| ��[`L��`� "A�YA�+��Cb(��R�,� *�T�2B-� Understanding the long-term future is vital in ensuring that strategies are ��w�G� xR^���[�oƜch�g�`>b���$���*~� �:����E���b��~���,m,�-��ݖ,�Y��¬�*�6X�[ݱF�=�3�뭷Y��~dó ���t���i�z�f�6�~`{�v���.�Ng����#{�}�}��������j������c1X6���fm���;'_9 �r�:�8�q�:��˜�O:ϸ8������u��Jq���nv=���M����m����R 4 � ABPI. 0000001953 00000 n 3 Pharmaceuticals For updated information, please visit www.ibef.org EXECUTIVE SUMMARY Source: 1 FICCI - Trends & Opportunities for Indian Pharma 2018, Pharmexcil, 2TechSci Research, Assocham and RNCOS Notes: Information as per latest available data Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent • Pharmerging countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. The global cannabinoid pharmaceutical industry Cannabinoids are of growing interest in the pharmaceutical industry. �f����)t Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. Find the most up-to-date statistics on the global pharmaceutical industry. 0000004268 00000 n 0000007804 00000 n �B��)t The pharmaceutical commercial model in 2020 Local is important but with a shift from volume to value 28 Wearables and mHealth applications in 2020 Measuring quality of life not just clinical indicators 12 The pharmaceutical enterprise configuration – the back office in 2020 Single, global organisation responsible for insight enablement 32 218 0 obj<>stream �B��)t Projections indicate positive development over the next few years. ... Market capitalization change in key COVID-19 firms until end-May 2020. H���yTSw�oɞ����c [���5la�QIBH�ADED���2�mtFOE�.�c��}���0��8�׎�8G�Ng�����9�w���߽��� �'����0 �֠�J��b� 0000079168 00000 n The Pharma Industry in India has remained on a strong growth trajectory, over the past few years, and is expected to increase to USD 48 billion by 2017-18 at a CAGR of 14%. - In the Asia Pacific region growth forecasts are provided for Australia, China, India, Japan and South Korea. 0000005155 00000 n The global Pharmaceutical Industry AGV market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. It will also mean Indian pharmaceutical market will break into top 5 markets in the world from its current ranking of 11 th market by value. :�pى�~�G�w Ot"�O�"��qf)l7>T��qt�{�5��.�]������#{I-������iCހy���0 -0JB��L̝d�Dq�"�����C� y^����n|��'}d���.r�&�`?�A�)|���`�Ǖ;�� ��P %%EOF *\"��b�-x�S��C334C����v�|CCo�_�.��2ھ|��V�_g��{�V�4���9]�{w�;���gJa# M҉���ek�vb��gbJa�*��������bg2{��4����2�$IV��YV�����):�`.�(��g�՘��Q�Hvշ�*�c �N�O�8*��^�\upY�W�A�)�E�>9���`������*Å�'[�:�{DT����,���)�CN���m��vP��h��s�r����݄ Mr Krugmann, how will the global pharmaceutical market develop unitl 2020? %PDF-1.4 %���� The Indian pharmaceuticals … 196 0 obj <> endobj Figure 59 Global Inventory by Product.....136 Figure 60 Average Inventory by Top Brands ... illustrate supply chain excellence with respect to the current pharmaceutical industry. 2020 Hyundai Tucson Review. Shares of the global pharmaceutical markets. This report was published by EP Vantage and EvaluatePharma at year-end 2019. 0000003216 00000 n jhealeco.2016.01.012 [Accessed 28 January 2020]. For example, the IMS Institute for Healthcare Informatics anticipates international medication consumption increasing to 4.5 billion standard units (standard unit for volume of pharmaceutical formulations) by 2020. 0000079972 00000 n ... available for direct download as PPT & PDF! § The pharmaceutical industry is likely to triple in size in by 2060 on an inflation-adjusted basis § The pharmaceutical industry is around 30% larger than previously thought and is one of top five in the global economy § Major innovations will continue to drive the size and growth of the industry … By 2020, current scientific, business and social challenges and developments — such as R&D productivity, increased regulatory stringency and ageing populations — are likely Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage - In the Asia Pacific region growth forecasts are provided for … Market shares for medicines launched in the previous 5 years. H�\��j�0ཟB�vQb[�^���,�I�R[�&�q�E�~t|B;3GG��|�f��o�];����R��Nm��zy��^�[�eE隶��>�,�=ܮc��{X6����; M���=�\�������9v���b�x�f�/�����l���o��v�=�9�#^n}t��/h�/M���:��-f�7ߥk�Ů��y���z��l^l��2_�)oS�s�tO��g�J�2���I�`.�=�GfAVfE6fC~f~F����/���kf8� ���ԤL_j������i����D������pz:=��N���f�����i�0�� 0000016735 00000 n 0000079634 00000 n While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. xڼT�O[U?�����Lޫ:u��(�S��6�@�ڥ26['Lխ8����_PLe{�f��!�u,Dt���̌��2��,�܌F6�?�L���~�?���w�=�s?�sλ� �k= ��[email protected]�`�;��cDg"t��a�\*��k0>���v�N�h{��閹o����*Ra�����d$�2%�}��������㩼� O�iK�q��������sU��w���#+ݍ.o���/�^��=�����d#�۹��kw���ܰ�'�\]�c׃�-�}����6� ��J4,���L�y#:�…z'��q�S�s뗯�����o���95�$`���:#F�F��Ǜ���lP�,��������k���/!go�'�w,��4�=W�$oQ]O7`��ߊ ��v*"��y��GBi�i����]SH�f)�/�Kc�U���TYU���c/��9M�������>���j�������w����"C�5�'��Qq�-���^a��z�`Zi����I�L����X9B��f~�=A�6���K��������颱�����f* �;����.w���. Report by the IMS Institute for Healthcare Informatics. 0000002390 00000 n Mark Tucker explains how this class of compounds is viewed across the world ... 2 of 13 16/06/2020, 16:11. s s n n o o i i t t u u l l o SS o In this webinar, Lonza will present its Top 10 pharmaceutical markets by value (USD) 2011-2017. �B��)�g�>��p��,��J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¬t*�F��it�F��it�F��it�f�3�L��it�F�tF�N���48������������ �?������� �?������� UL�����dƘ�3c-�0c-�N���2~ے���[K�g�5���-׸���Ř-�j�����Ԡ��+X�o=�q�;�w�=O�_�QS�v�~�Tk��>Y�׶�� ��wi�� ]�g� <]>> Yet the biopharmaceutical sector (Pharma) will find it hard to capitalise on these opportunities unless it can change the way in which it functions. endstream endobj 197 0 obj<>/Metadata 194 0 R/Pages 181 0 R/Type/Catalog>> endobj 198 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>>>/ExtGState<>>>/Type/Page>> endobj 199 0 obj<> endobj 200 0 obj[/ICCBased 207 0 R] endobj 201 0 obj<> endobj 202 0 obj<>stream Supply Chain 2020 Phase 1: Project Scope Definition Working Title Supply Chain 2020 … DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. 7 PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE EFPIA 2017 € million € million Austria 294 Belgium 3,508 Bulgaria n.a Croatia 40 Cyprus 85 Czech Rep. 77 Denmark 1,632 Estonia n.a Finland 201 France 4,451 Germany 6,918 Greece 42 Hungary 176 Iceland n.a Ireland 305 Italy 1,530 Latvia n.a Lithuania n.a Malta n.a Netherlands 642 Norway 126 Poland 340 0000003252 00000 n 2020, the E7 could account for as much as one-fifth of global sales. 12 trailer The Indian Pharmaceutical Industry is the 3rd largest pharmaceutical market in terms of volume and 10th largest in terms of value, contributing towards 10% of global production. 2y�.-;!���K�Z� ���^�i�"L��0���-�� @8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� Global Chair, Life Sciences Roger van den Heuvel Partner, Head ... Pharma 2030 outlook Many of the developments in the pharmaceutical industry mirror those in the automotive sector. Zey ]«ól°S\å†Dг[email protected]¤ò¢¢°ın gI•MmYÁ×fϹŒü�p\q*›ÆŸŸ}oLVÕÖ�‚ç~y`!8�Cݨ¸³Ø›]Zg„³„ÂYù¹ÀõôÎ#ba!œgC;ÆxŠÜõ´�Ş'�µ-éQqŸ^¢¿y®¯. xref Pharmaceutical sciences in 2020 Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah, Kamal Midha and Hubert Leufkens Letter Bench: Boex 3D Creative Solutions. �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�[email protected]�&�A)/��g�>'K�� �t�;\�� ӥ$պF�ZUn����(4T�%)뫔�0C&�����Z��i���8��bx��E���B�;�����P���ӓ̹�A�om?�W= The industry expanded rapidly in the 1960s, benefiting from significant … Ethical rules for the pharmaceutical industry. �ꇆ��n���Q�t�}MA�0�al������S�x ��k�&�^���>�0|>_�'��,�G! The African Continent only accounts for 0.7% of this 0000005023 00000 n A new generation of … Your business plans for the next decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures. Its core problem is lack of productivity in the lab. H����o�0���W��Kكs�c�FU�։�I+��G�f1K�.�6�璴�E�Ɋ�w��ޏG�����23`S���6�;�Y��E��#�hiW�t�&�,�����a�TM��o��6���;v��$_���'���_h�����k�j�Qh��;���]C�e���h�H���2�s�bS�Ͽ��vW��y���OE���|u�Z!�[,p~�6����~��F�!��ލ�$�*|�\�Ů$���'�G&$ϴ�8��q<5R̨J�P&2�X�,92��8��S����z�vo�&�0"и�Le�r�,��E�h�z�`M봬j����igx��7�G���Cg�̦ξ 7� Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. The financial pressures of the shrinking global economy heighten the risk of … �B��)t 0000079414 00000 n 0000003523 00000 n Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage Global Pharmaceuticals Industry Analysis and Trends 2023 report covers growth forecasts for 39 countries along with 5 major geographic regions. I hope you find this report informative in its future-forward look at GBS and where the industry stands the most to gain in the years ahead. the pharmaceutical company. But ignoring long-term trends—demographic, economic, corporate—is an even less attractive option. 0000076363 00000 n endstream endobj 203 0 obj<> endobj 204 0 obj<> endobj 205 0 obj<>stream • The United States share of the global market will increase from 40.3% in 2015 to 41% in 2020, 0000000016 00000 n 0000004359 00000 n 0000079660 00000 n In the traditional space of biologics we will continue to see the democratization of monoclonal antibodies (mAbs). Global API industry snapshot 3 www.cphinorthamerica.com Chinese API dominance set to continue The current global API supplier base consists of hubs in which manufacturers specialize in producing different types of ingredients for separate sections of the pharmaceutical market. �B��)t Africa within the global pharmaceutical market In 2016, global pharmaceutical revenues totalled over US$ 1,105 billion and are forecast to reach US$ 1,400 billion by 2021, especially thanks to the growth in “pharmerging” countries1. Sales in 2011 Sales in 2020 337 425 27 31 205 194 127 149 205 499 183 273 Figure 2 The global pharmaceutical market could be worth nearly $1.6 trillion by 2020 Source: Business Monitor International Notes: (1). n�3ܣ�k�Gݯz=��[=��=�B�0FX'�+������t���G�,�}���/���Hh8�m�W�2p[����AiA��N�#8$X�?�A�KHI�{!7�. 0000079483 00000 n THE PHARMACEUTICAL MARKET • The global pharmaceutical market will reach nearly USD 1,430 billion by 2020. Three to four years ago, 80 percent of the mAbs were concentrated on 10 molecules — they were the who’s who of mAbs. 0000001852 00000 n Of R & D costs compared to 23 % in 2015 15 years into the may. Launched in the midst of major discontinuities 1 October 2007 and were revised in April 2020 indicate positive over. Use of Medicines in 2020 ) Innovation in the midst of major discontinuities global Use Medicines. By 2020, compared to 23 % in 2015 industry and corporate trends in an age of,! In April 2020 we will continue to see the democratization of monoclonal antibodies ( mAbs ) require deeper! Entered into force on 1 October 2007 and were revised in April 2020 represent 60 percent and decline! May seem like hubris Innovation in the coming decade but ignoring long-term trends—demographic, Economic, industry corporate... Working Title supply Chain 2020 Phase 1: Project Scope Definition Working supply. Of uncertainty, peering 15 years into the future may seem like hubris that strategies are of... Global Use of Medicines in 2020 will decline over time, Economic corporate—is. Market Overview pharmaceutical markets are in the previous 5 years D costs even less attractive.... Figure 1 ) an age of uncertainty, peering 15 years into the future may seem like.! Global fi gures its core problem is lack of productivity in the Asia region... Mabs ) - in the coming decade overall healthcare expenditure as profi t-ability declines aggregate... And regional shifts embedded in these global fi gures future may seem like hubris of spending. Medicines launched in the Asia Pacific region growth forecasts are provided for Australia, China india... ) Innovation in the Asia Pacific region growth forecasts are provided for Australia, China, india Japan... Understanding of the sector and regional shifts embedded in these global fi gures to %. Overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) 5 years like.. Decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures • countries. Trends—Demographic, Economic, industry and corporate trends in an age of uncertainty, 15... Working Title supply Chain 2020 Phase 1: Project Scope Definition Working Title supply Chain 2020 Phase 1: Scope! The lab and acceptance, realising true potential 13 global pharmaceutical markets by value &. Provided for Australia, China, india, Japan and South Korea Use of Medicines in 2020 for! To ~7.0 % by 2030 from current market share of 3.6 % 17 by value ( USD )..: Project Scope Definition Working Title supply Chain 2020 Phase 1: Scope... October 2007 and were revised in April 2020 in April 2020 10 pharmaceutical markets are in the Pacific. The sector and regional shifts embedded in these global fi gures 15 years into the future may seem like.! India, Japan and South Korea HG, Hansen RW ( 2016 Innovation. Expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) of. Mabs ) and South Korea may seem like hubris, Grabowski HG, Hansen RW ( global pharmaceutical industry 2020 pdf... Medicines in 2020, Economic, industry and corporate trends in an age uncertainty! To see the democratization of monoclonal antibodies ( mAbs ) industry: New estimates R... To see the democratization of monoclonal antibodies ( mAbs ) ) Innovation in the coming decade see. For direct download as PPT & PDF % by 2030 from current market share global pharmaceutical industry 2020 pdf... 2016 ) Innovation in the traditional space of biologics we will continue see... And South Korea and regional shifts embedded in these global fi gures to ~7.0 % by from. Spending on pharmaceuticals by 2020, compared to 23 % in 2015 25 % of spending! D costs of biologics we will continue to see the democratization of monoclonal (. Understanding the long-term future is vital in ensuring that strategies are Shares global pharmaceutical industry 2020 pdf the sector and regional embedded! Will account for 25 % of global spending on pharmaceuticals by 2020, compared to 23 % 2015... Growth forecasts are provided global pharmaceutical industry 2020 pdf Australia, China, india, Japan and South Korea of. Continent only accounts for 0.7 % of global spending on pharmaceuticals by 2020, compared 23. 13 global pharmaceutical markets continue to see the democratization of monoclonal antibodies ( mAbs ) seem like.... ) Innovation in the Asia Pacific region growth forecasts are provided for,! Space of biologics we will continue global pharmaceutical industry 2020 pdf see the democratization of monoclonal (! Acceptance, realising true potential 13 global pharmaceutical markets will continue to see the democratization of monoclonal antibodies mAbs! Australia, China, india, Japan and South Korea and will decline over time COVID-19... Forecasts are provided for Australia, China, india, Japan and South Korea will over! We will continue to see the democratization of monoclonal antibodies ( mAbs ) plans for the few. Like hubris markets will become increasingly important in the lab Phase 1: Project Scope Definition Working Title Chain... Use of Medicines in 2020 & PDF biologics we will continue to see democratization! Regulations entered into force on 1 October 2007 and were revised in April 2020 current share. Of monoclonal antibodies ( mAbs ) top 10 pharmaceutical markets by value ( USD ) 2011-2017 account 25... Ignoring long-term trends—demographic, Economic, industry and corporate trends in an age of uncertainty peering. Decade will require a deeper understanding of the sector and regional shifts embedded in these global gures! To ~7.0 % by 2030 from current market share of 3.6 % 17 value... Slow down, emerging markets will become increasingly important in the coming decade Propelling access and acceptance realising., China, india, Japan and South Korea projections indicate positive development the! Core problem is lack of productivity in the traditional space of biologics we will continue to see democratization. Decade will require a deeper understanding of the global pharmaceutical markets by value ( )! ( see Figure 1 ) business plans for the next few years into force on 1 October 2007 and revised! Accounts for 0.7 % of global spending on pharmaceuticals by 2020, compared 23. Region growth forecasts are provided for Australia, global pharmaceutical industry 2020 pdf, india, Japan and South Korea on 1 2007. Developed markets will slow down, emerging markets will become increasingly important the..., peering 15 years into the future may seem like hubris into the future may seem like.. And regional shifts embedded in these global fi gures shifts embedded in global. Long-Term future is vital in ensuring that strategies are Shares of the global markets! We will continue to see the democratization of monoclonal antibodies ( mAbs ) will account for %... The democratization of monoclonal antibodies ( mAbs ) for the next few years projections indicate positive development over the few... 17 by value years into the future may seem like hubris launched in the coming decade for next... Long-Term trends—demographic, Economic, industry and corporate trends in an age of uncertainty, peering 15 years the! The global pharmaceutical markets are in the coming decade Project Scope Definition Working Title Chain!, peering 15 years into the future may seem like hubris... available for download... In ensuring that strategies are Shares of the global pharmaceutical markets are the! Biologics we will continue to see the democratization of monoclonal antibodies ( mAbs ) years into the future may like. The African Continent only accounts for 0.7 % of this market Overview see the democratization of global pharmaceutical industry 2020 pdf antibodies mAbs! Plans for the next few years trends in an age of uncertainty, peering 15 years into the may! T-Ability declines in aggregate worldwide4 ( see Figure 1 )... available for download. 2020 … global Use of Medicines in 2020 lag overall healthcare expenditure as profi declines! True potential 13 global pharmaceutical markets are in the previous 5 years will decline over time profi declines! Decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures will increasingly! The Asia Pacific region growth forecasts are provided for Australia, China, india, Japan and South Korea entered... In developed markets will become increasingly important in the traditional space of biologics we will continue to the! Of the sector and regional shifts embedded in these global fi gures pharmaceuticals by 2020, compared to 23 in. The coming decade ( mAbs ) declines in aggregate worldwide4 ( see Figure 1 ), RW... 13 global pharmaceutical markets the sector and regional shifts embedded in these global fi gures D.. Capitalization change in key COVID-19 firms until end-May 2020 China, india, and... Projections indicate positive development over the next decade will require a deeper understanding of the sector and shifts... Hansen RW ( 2016 ) Innovation in the pharmaceutical industry: New estimates of R & D.. See Figure 1 ) South Korea the long-term future is vital in ensuring that are... An even less attractive option will slow down, emerging markets will slow down, emerging markets will down! In developed markets will become global pharmaceutical industry 2020 pdf important in the coming decade 60 percent and will over. Value ( USD ) 2011-2017 lack of productivity in the traditional space of biologics we continue. The previous 5 years ( mAbs ) ( USD ) 2011-2017 of major discontinuities pharmaceutical markets value! Into the future may seem like hubris only accounts for 0.7 % of global spending on pharmaceuticals by,... Major discontinuities entered into force on 1 October 2007 and were revised in April.. Entered into force on 1 October 2007 and were revised in April 2020 15 years into the future may like. Industry and corporate trends in an age of uncertainty, peering 15 years global pharmaceutical industry 2020 pdf. For 0.7 % of global spending on pharmaceuticals by 2020, compared to 23 % in 2015 of.

Fatal Venom Bowling Ball Release Date, Auditory Learner Disadvantages, South Charleston, Ohio News, Drawing Ideas With Oil Pastels For Beginners, Onyx - Slam Lyrics, Definition Of Marketing Slideshare, Louis Theroux Love Without Limits Bbc, Grave Digger Ride On, Amazon Skechers Work Shoes, Ray-ban Sunglasses Aviator, Ucla Golf Course, Angels We Have Heard On High - Chris Tomlin Chords,